Location: New York, NY
CIK: 0001615982 · Show all filings
Period: Q3 2021 (← Previous) (Next →)
Filing Date: Nov 15, 2021
Total Value: $779M (100.0% shares, 0.0% debt)
| Ticker | Issuer | Shares | Value | % | Est. Cost | Unrealized | Class | CUSIP |
|---|---|---|---|---|---|---|---|---|
| — | INSTIL BIO INC | 6,865,076 | $123M | 15.8% | $25.08 | — | COM | 45783C101 |
| ACRS | ACLARIS THERAPEUTICS INC | 4,563,962 | $82.15M | 10.6% | $13.57 | +18.1% | COM | 00461U105 |
| CLDX | CELLDEX THERAPEUTICS INC | 1,098,174 | $59.29M | 7.6% | $15.71 | +198.7% | COM | 15117B202 |
| WHWK | AADI BIOSCIENCE INC | 1,529,402 | $44.92M | 5.8% | $30.48 | 0.0% | COM | 00032Q104 |
| — | VISTAGEN THERAPEUTICS INC | 16,047,286 | $43.97M | 5.6% | $2.02 | — | COM | 92840H202 |
| ALT | ALTIMMUNE INC | 3,800,000 | $42.98M | 5.5% | $6.02 | +102.0% | COM | 02155H200 |
| OLMA | OLEMA PHARMACEUTICALS INC | 1,536,193 | $42.34M | 5.4% | $46.89 | -42.4% | COM | 68062P106 |
| TVTX | TRAVERE THERAPEUTICS INC | 1,732,410 | $42.01M | 5.4% | $18.37 | 0.0% | COM | 89422G107 |
| RLMD | RELMADA THERAPEUTICS INC | 1,387,720 | $36.37M | 4.7% | $37.46 | -28.5% | COM | 75955J402 |
| GHRS | GH RESEARCH PLC | 1,642,296 | $36.23M | 4.7% | $20.41 | -0.3% | ORD SH | G3855L106 |
| — | KINNATE BIOPHARMA INC | 1,473,014 | $33.91M | 4.4% | $39.78 | — | COM | 49705R105 |
| — | MARINUS PHARMACEUTICALS INC | 2,641,809 | $30.06M | 3.9% | $12.27 | — | COM | 56854Q200 |
| — | GRAPHITE BIO INC | 1,612,617 | $26.43M | 3.4% | $30.73 | — | COM | 38870X104 |
| CNTA | CENTESSA PHARMACEUTICALS PLC | 1,127,272 | $18.82M | 2.4% | $22.21 | — | SPONS ADR | 152309100 |
| NUVL | NUVALENT INC | 803,951 | $18.13M | 2.3% | $29.01 | 0.0% | COM | 670703107 |
| CRVS | CORVUS PHARMACEUTICALS INC | 3,427,461 | $16.59M | 2.1% | $2.96 | 0.0% | COM | 221015100 |
| CGEM | CULLINAN ONCOLOGY INC | 706,050 | $15.94M | 2.0% | $40.60 | -34.1% | COM | 230031106 |
| ATYR | ATYR PHARMA INC | 1,565,000 | $14.21M | 1.8% | $5.98 | 0.0% | COM | 002120202 |
| — | ATHIRA PHARMA INC | 1,196,196 | $11.22M | 1.4% | $20.05 | — | COM | 04746L104 |
| PHVS | PHARVARIS NV | 552,882 | $9.803M | 1.3% | $31.46 | -45.6% | COM | N69605108 |
| COGT | COGENT BIOSCIENCES INC | 1,088,817 | $9.157M | 1.2% | $10.99 | -30.3% | COM | 19240Q201 |
| CVRX | CVRX INC | 533,370 | $8.822M | 1.1% | $28.00 | -31.5% | COM | 126638105 |
| — | AKOYA BIOSCIENCES INC | 400,000 | $5.584M | 0.7% | $19.34 | — | COM | 00974H104 |
| — | ASTRIA THERAPEUTICS INC | 538,999 | $4.765M | 0.6% | $8.84 | — | COM | 04635X102 |
| — | TRICIDA INC | 390,707 | $1.813M | 0.2% | $4.64 | — | COM | 89610F101 |
| VRDN | VIRIDIAN THERAPEUTICS INC | 19,495 | $321K | 0.0% | $15.07 | -2.7% | COM | 92790C104 |